$94.00
0.24% today
Nasdaq, Nov 20, 10:00 pm CET
ISIN
US15102K1007
Symbol
CELC

Celcuity Inc. Stock price

$94.23
+23.65 33.51% 1M
+83.54 781.48% 6M
+81.14 619.86% YTD
+81.76 655.65% 1Y
+84.53 871.44% 3Y
+85.29 954.03% 5Y
+79.94 559.41% 10Y
+79.94 559.41% 20Y
Nasdaq, Closing price Wed, Nov 19 2025
+2.63 2.87%
ISIN
US15102K1007
Symbol
CELC
Industry

Key metrics

Basic
Market capitalization
$4.4b
Enterprise Value
$4.2b
Net debt
positive
Cash
$455.0m
Shares outstanding
38.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
37.3
Financial Health
Equity Ratio
47.2%
Return on Equity
-96.7%
ROCE
-102.0%
ROIC
-
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-146.4m | $-166.4m
EBIT
$-146.6m | $-172.2m
Net Income
$-148.9m | $-150.2m
Free Cash Flow
$-120.7m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-72.3% | -47.0%
EBIT
-72.2% | -52.0%
Net Income
-79.7% | -34.4%
Free Cash Flow
-81.5%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-3.4
FCF per Share
$-3.1
Short interest
15.7%
Employees
87
Rev per Employee
$0.0
Show more

Is Celcuity Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Celcuity Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Celcuity Inc. forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a Celcuity Inc. forecast:

Buy
93%
Hold
7%

Financial data from Celcuity Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 13 13
96% 96%
-
- Research and Development Expense 134 134
70% 70%
-
-146 -146
72% 72%
-
- Depreciation and Amortization 0.15 0.15
25% 25%
-
EBIT (Operating Income) EBIT -147 -147
72% 72%
-
Net Profit -149 -149
80% 80%
-

In millions USD.

Don't miss a Thing! We will send you all news about Celcuity Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Celcuity Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for gedatolisib in hormone receptor positive (“HR+”), human epidermal growth factor recept...
Neutral
Seeking Alpha
8 days ago
Celcuity Inc. ( CELC ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Brian Sullivan - Co-Founder, Chairman & CEO Vicky Hahne - Chief Financial Officer Conference Call Participants Apoorva Chaloori Maurice Raycroft - Jefferies LLC, Research Division Tara Bancroft - TD Cowen, Research Division Bradley Canino - Guggenheim Securities, LLC, Research Division Dara Azar - St...
Neutral
GlobeNewsWire
8 days ago
Presented detailed efficacy and safety results from the PIK3CA wild-type (“WT”) cohort of the Phase 3 VIKTORIA-1 clinical trial at a late breaking oral presentation at the 2025 European Society for Medical Oncology (“ESMO”) Congress Presented updated clinical results from the Phase 1b portion of a clinical trial evaluating gedatolisib in combination with Nubeqa® (darolutamide) in men with metas...
More Celcuity Inc. News

Company Profile

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Head office United States
CEO Brian Sullivan
Employees 87
Founded 2012
Website www.celcuity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today